PDS Biotechnology Corporation

US$1.23As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PDSBHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (21.01%)
Div yield —
ROE (543.97%)
Biotechnology
Beta (5Y) 1.13
PE TTM —
TSR TTM 31.54%
Mkt cap US$89.14M
ROIC (98.61%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.48
20.57%
(46.71%)
Hold 6|9|3|12|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
23.58%
11.89%
1.36%
3.63%
Revenue$M
4.048
4.145
4.325
4.537
3.88%
3.78%
7.10%
10.37%
Peers (US$89.14M)
Cap (US$)
PE
90.19M
—
89.01M
131.4x
88.97M
—
Capital
TTM
5Y
10Y
Leveragex
0.801
(0.287)
(0.255)
EBIT/Intx
0.831
0.245
0.212
Own earn%
(65.39)
161.66
164.77
Sh yield%
40.89
65.18
65.48
Owners
Insiders/Inst%
4.07
89.21
Short interest%
2.32
SBC / revenue%
0.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
29–34
$1 testx
0.0
Incr. ROIC%
9